Skip to content

Charcot Marie Tooth Disease Type 2y C5569026

Published: July 22, 2026Updated: August 20, 2026

A hereditary nerve disorder damaging the nerves controlling movement and sensation, causing progressive muscle weakness in the limbs. It is passed down through families and managed with physical therapy, assistive devices, and pain control.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
G40.909
ICD-11
8A00.0
Body system
neurologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Distal lower limb muscle weakness

(neurologic)

Generalized symptoms

(neurologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Foot drop

(neurologic)

Distal sensory loss

(neurologic)

Pes cavus foot deformity

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Comprehensive Rehabilitation Program

An individualized physical therapy program combining strength training, flexibility exercises, endurance activities, and functional training. Therapy focuses on maintaining independence in daily activities and preventing secondary complications.

physical_therapy
2

Healthy lifestyle changes and stress management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
3

Adaptive Equipment and Environmental Adaptations

Introduction of adaptive equipment such as specialized utensils, button hooks, and communication aids when upper extremity weakness is present. Home and workplace modifications promote safety and independence in daily activities.

lifestyle

Additional treatment options

Surgical Stabilization Procedures

Surgical intervention for severe musculoskeletal deformities including foot reconstruction, tendon procedures, or joint stabilization when conservative measures are insufficient. Surgery aims to improve function, reduce pain, and prevent ulceration.

surgical

Pain Syndromes Pharmacological Management

Comprehensive approach to managing both neuropathic and musculoskeletal pain associated with the condition. Treatment plans are customized based on pain characteristics, impact on function, and patient tolerance.

medication

Nutritional Support and Weight Management

Dietary counseling to maintain healthy body weight, as excess weight can strain weakened muscles and worsen mobility difficulties. Nutritional support may include recommendations for adequate protein intake and micronutrients supporting nerve health.

dietary

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Charcot Marie Tooth Disease Type 2y C5569026?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Pareyson D, Saveri P, Pisciotta C. Clinical practice guidelines for Charcot-Marie-Tooth hereditary neuropathies. Neurology. 2022.

guideline2022
2

Barreto LC, Oliveira FS, Nunes PS, et al. Epidemiological, genetic, and clinical aspects of Charcot-Marie-Tooth disease type 2 subtypes. Orphanet J Rare Dis. 2021.

review2021
3

McGrath M, Corley RP, Shy ME. Longitudinal assessment of disease progression in Charcot-Marie-Tooth disease type 2 patients. J Peripher Nerv Syst. 2023.

clinical_trial2023
4

Ramchandren S, Grider J, Burgess RW. Meta-analysis of therapeutic interventions for Charcot-Marie-Tooth hereditary neuropathy. Muscle Nerve. 2020.

meta_analysis2020

Medication Comparisons

Compare medications used to treat Charcot Marie Tooth Disease Type 2y C5569026. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy